CN102573612B - 包含至少一种生物活性剂、制剂辅助物质和可磁化粒子的口服剂型 - Google Patents

包含至少一种生物活性剂、制剂辅助物质和可磁化粒子的口服剂型 Download PDF

Info

Publication number
CN102573612B
CN102573612B CN201080039021.4A CN201080039021A CN102573612B CN 102573612 B CN102573612 B CN 102573612B CN 201080039021 A CN201080039021 A CN 201080039021A CN 102573612 B CN102573612 B CN 102573612B
Authority
CN
China
Prior art keywords
dosage form
magnetic field
magnetic
particles
phase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201080039021.4A
Other languages
English (en)
Chinese (zh)
Other versions
CN102573612A (zh
Inventor
B·哈特维希
N·温德哈布
M·莱夫克
J·托米尔卡尔德
M·达姆
R·利兹奥
M·戈特沙尔克
A·奥尔夫
C·枚尔
A·格里柯兹克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roma Chemical Co ltd
Evonik Operations GmbH
Original Assignee
Evonik Roehm GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Roehm GmbH filed Critical Evonik Roehm GmbH
Publication of CN102573612A publication Critical patent/CN102573612A/zh
Application granted granted Critical
Publication of CN102573612B publication Critical patent/CN102573612B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN201080039021.4A 2009-09-03 2010-08-30 包含至少一种生物活性剂、制剂辅助物质和可磁化粒子的口服剂型 Expired - Fee Related CN102573612B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US23961309P 2009-09-03 2009-09-03
DE102009029170.9 2009-09-03
US61/239,613 2009-09-03
DE102009029170 2009-09-03
PCT/EP2010/062641 WO2011026808A1 (en) 2009-09-03 2010-08-30 Oral dosage form, comprising at least one biologically active agent, formulation auxiliary substances and magnetizable particles

Publications (2)

Publication Number Publication Date
CN102573612A CN102573612A (zh) 2012-07-11
CN102573612B true CN102573612B (zh) 2015-07-08

Family

ID=42984007

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201080039021.4A Expired - Fee Related CN102573612B (zh) 2009-09-03 2010-08-30 包含至少一种生物活性剂、制剂辅助物质和可磁化粒子的口服剂型

Country Status (13)

Country Link
US (1) US9050256B2 (enExample)
EP (1) EP2473095B1 (enExample)
JP (1) JP5868319B2 (enExample)
KR (1) KR101731130B1 (enExample)
CN (1) CN102573612B (enExample)
BR (1) BR112012004967B8 (enExample)
CA (1) CA2772708C (enExample)
ES (1) ES2528494T3 (enExample)
IL (1) IL217897A (enExample)
MX (1) MX2012002677A (enExample)
PL (1) PL2473095T3 (enExample)
SI (1) SI2473095T1 (enExample)
WO (1) WO2011026808A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014527968A (ja) * 2011-09-14 2014-10-23 ユニバーシティ オブ フロリダ Ｓｍａｒｔ（商標）固体経口剤
DE102011089334A1 (de) 2011-12-21 2013-06-27 Evonik Röhm Gmbh Detektionssystem zur Erfassung magnetischer Objekte im menschlichen Organismus
US11667906B2 (en) * 2014-11-24 2023-06-06 Corning Incorporated Magnetic microcarriers
US11024449B2 (en) * 2017-06-06 2021-06-01 Apple Inc. Multipole elastomeric magnet with magnetic-field shunt
MX2020005764A (es) 2017-12-04 2020-08-20 Evonik Operations Gmbh Enmascaramiento y visualizacion posterior de se?ales de resonancia de espin electronico (esr) utilizando la combinacion de dos materiales.
US10824822B2 (en) * 2019-02-05 2020-11-03 International Business Machines Corporation Magnetic tracking for medicine management
US10679018B1 (en) 2019-02-05 2020-06-09 International Business Machines Corporation Magnetic tracking for medicine management
JP7502741B2 (ja) * 2019-09-26 2024-06-19 スピンセンシングファクトリー株式会社 磁気マーカーおよび磁気マーカー検出システム
KR20230118075A (ko) 2020-10-09 2023-08-10 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 파브리병 치료를 위한 조성물 및 방법
CN112360304A (zh) * 2020-11-06 2021-02-12 炫丽建材江苏有限公司 一种适用于22度免拉手门板的自愈合封边工艺
US20220175812A1 (en) 2020-12-03 2022-06-09 Battelle Memorial Institute Polymer nanoparticle and dna nanostructure compositions and methods for non-viral delivery
AU2022253899A1 (en) 2021-04-07 2023-10-26 Battelle Memorial Institute Rapid design, build, test, and learn technologies for identifying and using non-viral carriers
KR20250007064A (ko) 2022-04-06 2025-01-13 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 Her2 양성 전이성 유방암 및 기타 암을 치료하기 위한 조성물 및 방법
WO2023196892A1 (en) 2022-04-06 2023-10-12 The Trustees Of The University Of Pennsylvania Passive immunization with anti- aav neutralizing antibodies to prevent off-target transduction of intrathecally delivered aav vectors
WO2025072751A1 (en) 2023-09-29 2025-04-03 Battelle Memorial Institute Polymer nanoparticle compositions for in vivo expression of polypeptides
US12441996B2 (en) 2023-12-08 2025-10-14 Battelle Memorial Institute Use of DNA origami nanostructures for molecular information based data storage systems

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079006A (en) * 1987-07-15 1992-01-07 Aprex Corporation Pharmaceutical compositions containing a magnetically detectable material
CN1094577A (zh) * 1994-02-02 1994-11-09 湖南省商业科技研究所 磁疗食品及其制备方法
CN1785430A (zh) * 2005-10-25 2006-06-14 南京工业大学 磁热疗用纳米磁粉－抗人肝癌单抗HAb18靶向药物
CN1909869A (zh) * 2004-01-22 2007-02-07 弗·哈夫曼-拉罗切有限公司 固体剂型

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3740187A1 (de) 1987-11-27 1989-06-08 Urquhart John Verfahren und vorrichtung zum ueberwachen und/oder kontrollieren und/oder registrieren und/oder anzeigen der einnahme von pharmazeutischen praeparaten
DE3940260A1 (de) 1989-03-04 1990-09-13 Werner Weitschies Verfahren zur bestimmung des aufenthaltsortes und der bewegung von objekten durch ihre markierung als magnetisches moment
DE19780856D2 (de) 1996-08-16 1999-09-23 Roche Diagnostics Gmbh Kontrollsystem für die Überwachung der regelmäßigen Einnahme eines Medikamentes
JP2004331750A (ja) * 2003-05-02 2004-11-25 Canon Inc ポリヒドロキシアルカノエートを含有する磁性構造体及びその製造方法ならびにその用途
EP1880716A1 (en) 2006-07-19 2008-01-23 Sandoz AG Kit of parts comprising an acid labile and an acid resistant pharmaceutically active ingredient
DE102008033662A1 (de) 2008-07-11 2010-01-14 Technische Universität Ilmenau Pharmakologische Darreichungsform und Vorrichtung und Verfahren zur kontinuierlichen Lokalisierung und Verfolgung des Auflösevorganges dieser

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079006A (en) * 1987-07-15 1992-01-07 Aprex Corporation Pharmaceutical compositions containing a magnetically detectable material
CN1094577A (zh) * 1994-02-02 1994-11-09 湖南省商业科技研究所 磁疗食品及其制备方法
CN1909869A (zh) * 2004-01-22 2007-02-07 弗·哈夫曼-拉罗切有限公司 固体剂型
CN1785430A (zh) * 2005-10-25 2006-06-14 南京工业大学 磁热疗用纳米磁粉－抗人肝癌单抗HAb18靶向药物

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
《Bioavailability of amoxicillin and clavulanic acid from extended release tablets depends on intragastric tablet deposition and gastric emptying》;W.Weitschies.eta;《European Journal of Pharmaceutics and Biopharmaceutics》;20081231(第70期);641-648 *
《Magnetic Marker Monitoring: An application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms》;Werner Weitschies,eta;《Advanced Drug Delivery Reviews》;20051231(第57期);1210-1222 *
《Magnetic marker monitoring: high resolution real-time tracking of oral solid dosage forms in the gastrointestinal tract》;Werner Weitschies，eta;《European Journal of Pharmaceutics and Biopharmaceutics》;20101231(第74期);93-101 *

Also Published As

Publication number Publication date
HK1168016A1 (en) 2012-12-21
JP5868319B2 (ja) 2016-02-24
BR112012004967A2 (pt) 2016-04-05
WO2011026808A1 (en) 2011-03-10
PL2473095T3 (pl) 2015-04-30
SI2473095T1 (sl) 2015-02-27
CA2772708A1 (en) 2011-03-10
EP2473095B1 (en) 2014-11-12
CA2772708C (en) 2017-07-11
ES2528494T3 (es) 2015-02-10
EP2473095A1 (en) 2012-07-11
US20120143039A1 (en) 2012-06-07
BR112012004967B8 (pt) 2022-07-05
JP2013503831A (ja) 2013-02-04
WO2011026808A8 (en) 2012-03-15
IL217897A (en) 2014-06-30
KR101731130B1 (ko) 2017-05-11
BR112012004967B1 (pt) 2021-05-11
CN102573612A (zh) 2012-07-11
MX2012002677A (es) 2012-04-11
US9050256B2 (en) 2015-06-09
IL217897A0 (en) 2012-03-29
KR20120060210A (ko) 2012-06-11

Similar Documents

Publication Publication Date Title
CN102573612B (zh) 包含至少一种生物活性剂、制剂辅助物质和可磁化粒子的口服剂型
Balamuralidhara et al. pH sensitive drug delivery systems: a review
US9696279B2 (en) Detection system for detecting magnetic objects in the human organism
Xing et al. Oral colon-specific drug delivery for bee venom peptide: development of a coated calcium alginate gel beads-entrapped liposome
US12383495B2 (en) Resident articles for gram-level dosing
US10165988B2 (en) Personalized detection system for detecting magnetic objects in the human organism
Corá et al. Pharmaceutical applications of AC Biosusceptometry
HK1168016B (en) Oral dosage form, comprising at least one biologically active agent, formulation auxiliary substances and magnetizable particles
Burke et al. A novel method to radiolabel gastric retentive formulations for gamma scintigraphy assessment
Mahmoud et al. A Deployable 4D Printed, Mucoadhesive and Magnetically Guided Patch for Local Therapy of Gastric Cancer
Arora et al. Radiopharmaceutical-based approaches for the determination of colon-targeting efficiency
Cora et al. Magnetic images with a biosusceptometer of pharmaceutical dosage forms in the human gastrointestinal tract
HK1199397B (en) Detection system for detecting magnetic objects in the human organism
Rezaeifar Multiparticulate systems based on enteric polymers

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1168016

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1168016

Country of ref document: HK

CP01 Change in the name or title of a patent holder

Address after: Essen, Germany

Patentee after: Evonik Operations Ltd.

Address before: Essen, Germany

Patentee before: EVONIK DEGUSSA GmbH

Address after: Darmstadt, Germany

Patentee after: Roma Chemical Co.,Ltd.

Address before: Darmstadt, Germany

Patentee before: EVONIK ROHM GmbH

CP01 Change in the name or title of a patent holder
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20200619

Address after: Essen, Germany

Patentee after: EVONIK DEGUSSA GmbH

Address before: Darmstadt, Germany

Patentee before: Roma Chemical Co.,Ltd.

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150708